OrthoPediatrics Corp Business Acquisition, Pro Forma Revenue
OrthoPediatrics Corp (KIDS) reported Business Acquisition, Pro Forma Revenue of $205.16 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-03-04
- OrthoPediatrics Corp business acquisition, pro forma revenue for the quarter ending 2024-12-31 was $52.67M, a 16.27% increase year-over-year.
- OrthoPediatrics Corp business acquisition, pro forma revenue for the quarter ending 2024-09-30 was $54.57M, a 17.15% increase year-over-year.
- OrthoPediatrics Corp business acquisition, pro forma revenue for the quarter ending 2024-06-30 was $52.80M, a 15.20% increase year-over-year.
- OrthoPediatrics Corp business acquisition, pro forma revenue for the quarter ending 2024-03-31 was $45.12M, a 17.38% increase year-over-year.
- OrthoPediatrics Corp business acquisition, pro forma revenue for fiscal 2024 was $205.16M, a 16.47% increase from fiscal 2023.
- OrthoPediatrics Corp business acquisition, pro forma revenue for fiscal 2023 was $176.15M, a 36.93% increase from fiscal 2022.
- OrthoPediatrics Corp business acquisition, pro forma revenue for fiscal 2022 was $128.65M, a 12.95% increase from fiscal 2021.
- OrthoPediatrics Corp business acquisition, pro forma revenue for fiscal 2021 was $113.90M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 6 month as first filed | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $52.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $107.24M derived: sum of 2 quarters · filed 2026-03-04 | $160.04M derived: sum of 3 quarters · filed 2026-03-04 | $205.16M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $54.57M 10-Q · filed 2024-11-07 | $107.38M derived: sum of 2 quarters · filed 2024-11-07 | $152.49M 10-Q · filed 2024-11-07 | $197.79M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-06-30 | $52.80M 10-Q · filed 2024-08-06 | $97.92M 10-Q · filed 2024-08-06 | $143.22M derived: sum of 3 quarters · filed 2026-03-04 | $189.80M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-03-31 | $45.12M 10-Q · filed 2024-05-07 | $90.41M derived: sum of 2 quarters · filed 2026-03-04 | $137.00M derived: sum of 3 quarters · filed 2026-03-04 | $182.84M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2023-12-31 | $45.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $91.88M derived: sum of 2 quarters · filed 2026-03-04 | $137.72M derived: sum of 3 quarters · filed 2026-03-04 | $176.15M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | $46.59M 10-Q · filed 2024-11-07 | $39.97M 10-Q · filed 2023-11-07 | $92.42M derived: sum of 2 quarters · filed 2024-11-07 | $130.86M 10-Q · filed 2024-11-07 | $111.12M 10-Q · filed 2023-11-07 | $160.73M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $45.84M 10-Q · filed 2024-08-06 | $39.56M 10-Q · filed 2023-08-01 | $84.27M 10-Q · filed 2024-08-06 | $71.15M 10-Q · filed 2023-08-01 | $114.14M derived: sum of 3 quarters · filed 2024-08-06 | $149.09M derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $38.44M 10-Q · filed 2024-05-07 | $31.59M 10-Q · filed 2023-05-02 | $68.30M derived: sum of 2 quarters · filed 2024-05-07 | $103.25M derived: sum of 3 quarters · filed 2024-05-07 | $138.34M derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $29.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $64.82M derived: sum of 2 quarters · filed 2024-03-08 | $99.91M derived: sum of 3 quarters · filed 2024-03-08 | $128.65M 10-K · filed 2024-03-08 | |||
| 2022-09-30 | $34.95M 10-Q · filed 2023-11-07 | $70.04M derived: sum of 2 quarters · filed 2023-11-07 | $98.78M 10-Q · filed 2023-11-07 | $125.26M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-06-30 | $35.09M 10-Q · filed 2023-08-01 | $62.95M 10-Q · filed 2023-08-01 | $90.31M derived: sum of 3 quarters · filed 2024-03-08 | $119.99M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-03-31 | $27.86M 10-Q · filed 2023-05-02 | $55.22M derived: sum of 2 quarters · filed 2024-03-08 | $84.90M derived: sum of 3 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $27.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $57.03M derived: sum of 2 quarters · filed 2024-03-08 | $113.90M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $29.68M 10-Q · filed 2022-11-01 | $86.54M 10-Q · filed 2022-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |